Inventor · disambiguated record
Ryan Hudson
Also filed as: HUDSON RYAN · HUDSON RYAN DAVID · HUDSON RYAN E
62 granted patents·16 pending applications·301 citations·filing 2003–2025
98Inventor score
Files withTHERAVANCE BIOPHARMA R&D IP LLC18UNITY BIOTECHNOLOGY INC13PAYPAL INC6CHOI SEOK-KI5NEUMORA THERAPEUTICS INC5
Top patents by PatentIndex Score
78 records- 0198US7777077B2Dual-acting antihypertensive agentsTHERAVANCE INC·Filed 2008·Granted Aug 17, 2010·34 cites·34 claims
- 0297US11420965B2Pyrimidine compound as JAK kinase inhibitorTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Granted Aug 23, 2022·3 cites·18 claims
- 0397US10774080B2Pyrimidine compound as JAK kinase inhibitorTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2020·Granted Sep 15, 2020·5 cites·22 claims
- 0497US9725470B2Substituted naphthyridines as JAK kinase inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2016·Granted Aug 8, 2017·27 cites·19 claims
- 0597US7834041B2Dual-acting antihypertensive agentsTHERAVANCE INC·Filed 2008·Granted Nov 16, 2010·29 cites·24 claims
- 0696US11780852B2Methods for treating Crohn's disease using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrileTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Granted Oct 10, 2023·3 cites·55 claims
- 0796US10988470B2Pyrimidine compound as JAK kinase inhibitorTHERAVANCE BIOPHARMA R & D IP LLC·Filed 2020·Granted Apr 27, 2021·3 cites·19 claims
- 0896US10562894B2Pyrimidine compound as JAK kinase inhibitorTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Feb 18, 2020·7 cites·19 claims
- 0996US10308646B2Pyrimidine compound as JAK kinase inhibitorTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Jun 4, 2019·11 cites·32 claims
- 1096US8563512B2Neprilysin inhibitorsSMITH CAMERON·Filed 2011·Granted Oct 22, 2013·62 cites·22 claims
- 1196US8372984B2Dual-acting oxazole antihypertensive agentsTHERAVANCE INC·Filed 2010·Granted Feb 12, 2013·16 cites·15 claims
- 1295US10140625B2Systems and methods for interfacing with a website to modify contentHONEY SCIENCE CORP·Filed 2017·Granted Nov 27, 2018·14 cites·19 claims
- 1395US10028960B2Pyrimidine compounds as JAK kinase inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2017·Granted Jul 24, 2018·18 cites·13 claims
- 1494US7956054B2Dual-acting pyrazole antihypertensive agentsTHERAVANCE INC·Filed 2010·Granted Jun 7, 2011·21 cites·16 claims
- 1592US10981892B2Acyl sulfonamides that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancerUNITY BIOTECHNOLOGY INC·Filed 2020·Granted Apr 20, 2021·2 cites·1 claims
- 1692US10947254B2Methods for treating ulcerative colitis using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrileTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Mar 16, 2021·3 cites·56 claims
- 1792US10679233B2Systems and methods for interfacing with a website to modify contentHONEY SCIENCE CORP·Filed 2019·Granted Jun 9, 2020·5 cites·20 claims
- 1890US2025188055A1Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating CancerUNITY BIOTECHNOLOGY INC·Filed 2024·Application pending·0 cites
- 1989US12358931B23-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl) propanenitrile as a JAK kinase inhibitorTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2023·Granted Jul 15, 2025·0 cites·5 claims
- 2089US11110095B2Pyrimidine compounds as JAK kinase inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Sep 7, 2021·3 cites·22 claims
- 2189US10961267B2Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory diseaseTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Mar 30, 2021·3 cites·18 claims
- 2289US10519197B1Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancerUNITY BIOTECHNOLOGY INC·Filed 2019·Granted Dec 31, 2019·3 cites·14 claims
- 2388US12172994B2Pyrimidine compound as JAK kinase inhibitorTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2023·Granted Dec 24, 2024·0 cites·19 claims
- 2488US10726437B2Systems and methods for interfacing with a website to modify contentHONEY SCIENCE LLC·Filed 2020·Granted Jul 28, 2020·2 cites·28 claims
- 2588US10719843B2Systems and methods for interfacing with a website to modify contentHONEY SCIENCE LLC·Filed 2020·Granted Jul 21, 2020·2 cites·30 claims
- 2688US10685368B1Systems and methods for interfacing with a website to modify contentHONEY SCIENCE LLC·Filed 2020·Granted Jun 16, 2020·2 cites·30 claims
- 2787US10614476B2Systems and methods for interfacing with a website to modify contentHONEY SCIENCE CORP·Filed 2018·Granted Apr 7, 2020·2 cites·13 claims
- 2886US12354127B2Systems and methods for interfacing with a website to modify contentPAYPAL INC·Filed 2023·Granted Jul 8, 2025·0 cites·20 claims
- 2986US10717722B2Acyl sulfonamides that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancerUNITY BIOTECHNOLOGY INC·Filed 2019·Granted Jul 21, 2020·2 cites·9 claims
- 3085US11625742B2Systems and methods for interfacing with a website to modify contentPAYPAL INC·Filed 2020·Granted Apr 11, 2023·1 cites·20 claims
- 3182US12371414B2Methods of treating neurological disordersNEUMORA THERAPEUTICS INC·Filed 2024·Granted Jul 29, 2025·0 cites·6 claims
- 3282US11993580B1Methods of treating neurological disordersNEUMORA THERAPEUTICS INC·Filed 2023·Granted May 28, 2024·0 cites·6 claims
- 3382US11814377B2Pyrimidine compound as JAK kinase inhibitorTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2022·Granted Nov 14, 2023·0 cites·19 claims
- 3482US8119634B2Dual-acting pyrazole antihypertensive agentsBLAIR BROOKE·Filed 2011·Granted Feb 21, 2012·6 cites·11 claims
- 3581US2024383884A1Compounds and methods for modulating interleukin-2-inducible t-cell kinaseCORVUS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3679US11008314B2Compounds and methods for modulating interleukin-2-inducible t-cell kinaseCORVUS PHARMACEUTICALS INC·Filed 2017·Granted May 18, 2021·1 cites·30 claims
- 3779US9555041B2Neprilysin inhibitorsSMITH CAMERON·Filed 2015·Granted Jan 31, 2017·2 cites·17 claims
- 3879US9120758B2Neprilysin inhibitorsSMITH CAMERON·Filed 2013·Granted Sep 1, 2015·3 cites·34 claims
- 3978US12221433B2Acyl sulfonamides that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancerUNITY BIOTECHNOLOGY INC·Filed 2021·Granted Feb 11, 2025·0 cites·1 claims
- 4078US11893595B2Systems and methods for interfacing with a website to modify contentPAYPAL INC·Filed 2021·Granted Feb 6, 2024·0 cites·33 claims
- 4178US10870652B2Compounds and methods for modulating bruton's tyrosine kinaseCORVUS PHARMACEUTICALS INC·Filed 2017·Granted Dec 22, 2020·2 cites·28 claims
- 4278US8143298B2Dual-acting antihypertensive agentsCHOI SEOK-KI·Filed 2010·Granted Mar 27, 2012·1 cites·6 claims
- 4377US11961103B2Systems and methods for dynamically modifying content of a websitePAYPAL INC·Filed 2022·Granted Apr 16, 2024·0 cites·20 claims
- 4477US8106082B2Dual-acting antihypertensive agentsCHOI SEOK-KI·Filed 2010·Granted Jan 31, 2012·3 cites·22 claims
- 4577US2024354796A1Systems and methods for dynamically modifying content of a websitePAYPAL INC·Filed 2024·Application pending·0 cites
- 4673US2023365534A1Modulators of nlrp3 inflammasome and related products and methodsNEUMORA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4772US11608354B2Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory diseaseTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Granted Mar 21, 2023·0 cites·11 claims
- 4871US11897874B2Compounds and methods for modulating Interleukin-2-inducible T-cell kinaseCORVUS PHARMACEUTICALS INC·Filed 2021·Granted Feb 13, 2024·0 cites·29 claims
- 4971US2025304560A1Modulators of nlrp3 inflammasome and related products and methodsNEUMORA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 5069US8637676B2Dual-acting benzoimidazole antihypertensive agentsALLEGRETTI PAUL·Filed 2008·Granted Jan 28, 2014·0 cites·33 claims
Showing the top 50 of 78 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ryan Hudson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →